We are investigating aberrant glutamine metabolism in breast cancer to discover potential novel therapeutic targets to inhibit a critical energy source for cancer cells. We have examined glutamine and glutamate levels using 1H magnetic resonance spectroscopy (MRS) across multiple breast cancer cell types and have begun to look at the molecular mechanisms of glutamine addiction using qRT-PCR. We identified SLC38A3 to be overexpressed in nearly every breast cancer cell line examined, which may, in the future, serve as a potential target in breast cancer.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords